Corbus Pharmaceuticals Holdings, Inc.
CRBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595097
In the last 90 days, Corbus Pharmaceuticals Holdings, Inc. insiders filed 1 open-market purchase and 3 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $129.1M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Corbus Pharmaceuticals Holdings, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 107
- +26 vs. Q1 2024
- Shares held
- 10.8M
- +2.22M (+26.1%) vs. Q1 2024
- Total value
- $486.1M
- +$151.4M (+45.2%) vs. Q1 2024
- New holders
- 41
- 23 more added
- Sold out
- 15
- 24 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 107 | $129.1M |
| Q1 2026 | 108 | $121.2M |
| Q4 2025 | 101 | $108.4M |
| Q3 2025 | 81 | $111.5M |
| Q2 2025 | 80 | $62.5M |
| Q1 2025 | 86 | $55.4M |
| Q4 2024 | 99 | $129.3M |
| Q3 2024 | 107 | $243.1M |
| Q2 2024 | 107 | $486.1M |
| Q1 2024 | 82 | $334.7M |
| Q4 2023 | 34 | $4.53M |
| Q3 2023 | 27 | $5.01M |
| Q2 2023 | 28 | $5.80M |
| Q1 2023 | 30 | $5.26M |
| Q4 2022 | 63 | $1.31M |
| Q3 2022 | 65 | $3.86M |
| Q2 2022 | 71 | $8.04M |
| Q1 2022 | 73 | $19.7M |
| Q4 2021 | 83 | $27.2M |
| Q3 2021 | 87 | $45.6M |
| Q2 2021 | 99 | $91.0M |
| Q1 2021 | 107 | $86.2M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Corbus Pharmaceuticals Holdings, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 332,761 | $15.1M | 0.01% | −36,406−9.9% | Reduced |
| Adage Capital Partners GP, L.L.C. | 400,000 | $18.1M | 0.03% | −15,000−3.6% | Reduced |
| State Street Corp | 442,333 | $20.0M | 0.00% | +406,354+1,129.4% | Added |
| Octagon Capital Advisors LP | 488,000 | $22.1M | 3.64% | +83,000+20.5% | Added |
| Vanguard Group Inc | 584,989 | $26.5M | 0.00% | +147,725+33.8% | Added |
| BlackRock Inc. | 761,367 | $34.5M | 0.00% | +540,505+244.7% | Added |
| Cormorant Asset Management, LP | 2,025,000 | $91.6M | 5.33% | 00.0% | Unchanged |
| Altitude Crest Partners Inc. | 0 | $0 | 0.00% | −103,703−100.0% | Sold out |
| Prosight Management, LP | 0 | $0 | 0.00% | −100,617−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −88,934−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −24,880−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −17,673−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −15,304−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −14,943−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −12,314−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −10,290−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −10,123−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −401−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −507−100.0% | Sold out |
| Cutler Group LP | – | – | – | – | Not filed |